Roser Pinyol

9PUBLICATIONS
141CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 04, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillance.

Xin Li, Cynthia Lebeaupin, Aikaterini Kadianaki

|Dec 08, 2025
Effective therapeutic targeting of CTNNB1-mutant hepatoblastoma with WNTinib.

Ugne Balaseviciute, Júlia Huguet-Pradell, Jordi Abril-Fornaguera

|Sep 23, 2025
E7386 Enhances Lenvatinib's Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma.

Agavni Mesropian, Albert Gris-Oliver, Ugne Balaseviciute

|Feb 19, 2025
Human-correlated genetic models identify precision therapy for liver cancer.

Miryam Müller, Stephanie May, Holly Hall

|Feb 29, 2024
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma.

Josep M Llovet, Roser Pinyol, Mark Yarchoan

|Feb 13, 2023
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.

Jordi Abril-Fornaguera, Laura Torrens, Carmen Andreu-Oller

Pageof 2

Frequent Collaborators

6 joint publications

Josep M Llovet

4 joint publications

Carla Montironi

4 joint publications

Albert Gris-Oliver

4 joint publications

Jordi Abril-Fornaguera